Bavituximab, known as TRWH-783, represents a innovative therapeutic technique targeting phosphatidylserine (PS). PS is usually a inside lipid found inside cell membranes; however, it's often displayed on the outer of cancer cells and dying cells, serving as an “eat me” indicator for phagocytic cells. This molecule specifically targets PS, aimin